Bishal Gyawali: ESMO Global Consortium Study on the availability, affordability, and accessibility of cancers medicines
Bishal Gyawali, Associate Professor at Queen’s University, Kingston, posted on X about recent paper by N.I. Cherny et al., titled “ESMO Global Consortium Study on the availability, out-of-pocket costs, and accessibility of cancer medicines: 2023 update” published on ESMO Annals of Oncology.
Authors: N.I. Cherny, D. Trapani, M. Galotti, M. Saar, G. Bricalli, F. Roitberg, B. Gyawali, G. Curigliano, J.-Y. Blay, K. Meier, N.J. Latino, E.G.E. de Vries
“Published today in ESMO Annals of Oncology, the results from our updated ESMO Global consortium study on the availability, affordability, and accessibility of cancers medicines.”
Bishal Gyawali, MD, PhD, is a medical oncologist from Nepal. Currently an Associate Professor at Queen’s University, Kingston, Canada, and affiliated with Brigham and Women’s Hospital, Boston, USA, he is involved in global oncology initiatives. Dr. Gyawali serves on several committees, including the WHO Essential Medicines List Cancer Medicines Working Group and ASCO’s Health Equity and Outcomes Committee, contributing significantly to cancer policy and evidence-based oncology.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023